In this insightful discussion, Dr. Betty Raman, an Oxford researcher studying the effects of Long Covid on the body, joins Bill Hinshaw, CEO of Axcella Therapeutics, who is developing innovative mitochondrial therapies. They dive into how mitochondrial dysfunction might drive the debilitating fatigue associated with Long Covid. The conversation highlights groundbreaking MRI findings revealing organ abnormalities and explores a promising treatment trial, AXA1125, aimed at restoring mitochondrial health and potentially alleviating fatigue for countless sufferers.
